Kathleen McKee is a Neurology physician affiliated with Intermountain Healthcare. OpenAlex indexes 40 publications with 654 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Rapid Cadence Cycling for Parkinson's Disease: A Study of Implementation and Efficacy in the Community Setting
Sponsor: Massachusetts General Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Amneal Pharmaceuticals LLCProgram year20251 payment
- Medtronic, Inc.Program year202415 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
96.8%Aromatic Amino Acid Decarboxylation Inhibitor48%Carbidopa-Levodopa68%Carbidopa-Levodopa Er32%Part D≥51 patientsSSRI17.7%Trazodone Hcl55%Escitalopram Oxalate46%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
3.2%Chloride Channel Activator3.2%Lubiprostone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Advice to people with Parkinson's in my clinic: Get a cardiopulmonary exercise test
Journal of Parkinson s Disease
2025 - Creating and Evaluating a Prediction Equation for VO2peak in Individuals with Early Stage, Never Medicated Parkinson’s Disease
Medicine & Science in Sports & Exercise
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Kirk Knowlton, MD
Intermountain Healthcare
Fabiana Ostronoff, MD
Intermountain Healthcare
Marcelo Di Carli, MD
Intermountain Healthcare
Brian Whisenant, MD
Intermountain Healthcare
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”